You are here

  • Home
  • Archive
  • Volume 11, Issue 3
  • Effectiveness of vedolizumab dose intensification to achieve inflammatory bowel disease control in cases of suboptimal response

Article metrics

Article menu
Download PDFPDF
Colorectal
Original research
Effectiveness of vedolizumab dose intensification to achieve inflammatory bowel disease control in cases of suboptimal response

 

Online download statistics by month:

Online download statistics by month: July 2019 to March 2024

AbstractFullPdf
Jul 20195704537
Aug 2019922214
Sep 20195452
Oct 20194869
Nov 20197623
Dec 20193910
Jan 20206033
Feb 20207044
Mar 20204067
Apr 20201972518
May 20204864547
Jun 20202402620
Jul 202013548
Aug 2020842210
Sep 2020100812
Oct 202011627
Nov 202086310
Dec 202094412
Jan 2021116211
Feb 2021116513
Mar 20219726
Apr 20216717
May 20214259
Jun 20211179
Jul 2021217
Aug 2021113
Sep 20211486
Oct 20215471
Nov 2021101106
Dec 202171105
Jan 20224612
Feb 20226855
Mar 20228074
Apr 20228526
May 202211623
Jun 20227961
Jul 20228944
Aug 20228610
Sep 202291121
Oct 2022206711
Nov 202210403
Dec 20227843
Jan 20237210
Feb 202312020
Mar 20234123
Apr 20234132
May 20234820
Jun 20233461
Jul 20236833
Aug 20236311
Sep 20233122
Oct 20235722
Nov 202313341
Dec 20234000
Jan 20244654
Feb 20242833
Mar 202463103
Total5292389374